86 results on '"Hellard Margaret"'
Search Results
2. Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar
3. Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta‐analysis
4. Communication to promote and support physical distancing for COVID-19 prevention and control
5. The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia
6. Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility
7. Infectious syphilis in women and heterosexual men in major Australian cities: sentinel surveillance data, 2011–2019
8. Validation of a novel point‐of‐care test for alanine aminotransferase measurement: A pilot cohort study
9. The cost‐effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030
10. Chlamydia prevention and management in Australia: reducing the burden of disease
11. Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort
12. Role of COVID ‐19 vaccine education in discharge planning to increase community vaccination coverage
13. The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study
14. A multi‐site, nurse‐coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia
15. Letter in response: Psychiatrists can treat hepatitis C
16. Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia
17. Outcomes of the CT2 study: A ‘one‐stop‐shop’ for community‐based hepatitis C testing and treatment in Yangon, Myanmar
18. Patient‐reported outcomes of the Treatment and Prevention Study: A real‐world community‐based trial of direct‐acting antivirals for hepatitis C among people who inject drugs
19. Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale‐up of direct‐acting antiviral treatment
20. A qualitative exploration of enablers for hepatitis B clinical management among ethnic Chinese in Australia
21. Hepatitis C treatment in a co‐located mental health and alcohol and drug service using a nurse‐led model of care
22. Authors’ response to Letter to the Editor: ‘Colombian experience in the management of hepatitis C’
23. In support of community‐based hepatitis C treatment with triage of people at risk of cirrhosis to specialist care
24. Estimates of the global reduction in liver disease-related mortality with increased coffee consumption: an analysis of the Global Burden of Disease Dataset
25. Hepatitis C elimination in people living with HIV – the importance of biomedical and behavioural interventions
26. Enhancing the hepatitis B care cascade in Australia: A cost‐effectiveness model
27. Measuring hepatitis C virus elimination as a public health threat: Beyond global targets
28. Blood donation amongst people who inject drugs in Australia: research supporting policy change
29. HIV pre‐exposure prophylaxis for female sex workers: ensuring women’s family planning needs are not left behind
30. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
31. Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse
32. Assessment of service refinement and its impact on repeatHIVtesting by client's access to Australia's universal healthcare system: a retrospective cohort study
33. Use of long‐acting reversible contraception in a cluster‐random sample of female sex workers in Kenya
34. Staying hepatitis C negative: A systematic review and meta‐analysis of cure and reinfection in people who inject drugs
35. Hepatitis C risk perceptions and attitudes towards reinfection amongHIV‐diagnosed gay and bisexual men in Melbourne, Australia
36. Community‐based, point‐of‐care hepatitis C testing: perspectives and preferences of people who inject drugs
37. Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004–2015
38. A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015
39. Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study
40. Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience
41. Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030
42. Eliminating hepatitis C: The importance of frequent testing of people who inject drugs in high-prevalence settings
43. Undiagnosed HIV infections among gay and bisexual men increasingly contribute to new infections in Australia
44. Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era
45. A tale of two countries: progress towards UNAIDS 90‐90‐90 targets in Botswana and Australia
46. Undiagnosed HIV infections among gay and bisexual men increasingly contribute to new infections in Australia
47. Eliminating hepatitis C virus as a public health threat among HIV‐positive men who have sex with men: a multi‐modelling approach to understand differences in sexual risk behaviour
48. The role of living context in prescription opioid injection and the associated risk of hepatitis C infection
49. Cost‐effectiveness of treating chronic hepatitis C virus with direct‐acting antivirals in people who inject drugs in Australia
50. The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.